Niagen Bioscience, Inc.
NAGE· Nasdaq
NAGENiagen Bioscience, Inc.
Filed Aug 11, 2011 · 10-Q · 40 days after period end · 0001415889-11-000758
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Revenue | $1.94M | $2.03M |
| Net Income | -$1.84M | -$303.53K |
| EPS Diluted | -$0.03 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Niagen Bioscience, Inc. · CIK 1386570 · Engraved from SEC EDGAR
ended Jul 2, 2011 · filed Aug 11, 2011 · 40 d after period end
